198 related articles for article (PubMed ID: 27537596)
1. Bleeding recurrence in patients with gastrointestinal vascular malformation after thalidomide.
Chen H; Fu S; Feng N; Chen H; Gao Y; Zhao Y; Xue H; Zhang Y; Li X; Dai J; Fang J; Ge Z
Medicine (Baltimore); 2016 Aug; 95(33):e4606. PubMed ID: 27537596
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation.
Ge ZZ; Chen HM; Gao YJ; Liu WZ; Xu CH; Tan HH; Chen HY; Wei W; Fang JY; Xiao SD
Gastroenterology; 2011 Nov; 141(5):1629-37.e1-4. PubMed ID: 21784047
[TBL] [Abstract][Full Text] [Related]
3. The role of HIF-1, angiopoietin-2, Dll4 and Notch1 in bleeding gastrointestinal vascular malformations and thalidomide-associated actions: a pilot in vivo study.
Tan HH; Ge ZZ; Gao YJ; Chen HM; Fang JY; Chen HY; Liu WZ; Xiao SD
J Dig Dis; 2011 Oct; 12(5):349-56. PubMed ID: 21955427
[TBL] [Abstract][Full Text] [Related]
4. [The potential pathogenesis of gastrointestinal vascular malformation and the potential mechanism of thalidomide in the treatment of gastrointestinal vascular malformation].
Feng Q; Tan HH; Ge ZZ; Gao YJ; Chen HM; Fang JY; Xiao SD
Zhonghua Nei Ke Za Zhi; 2012 May; 51(5):385-9. PubMed ID: 22883339
[TBL] [Abstract][Full Text] [Related]
5. Effective treatment of gastrointestinal bleeding with thalidomide--Chances and limitations.
Bauditz J
World J Gastroenterol; 2016 Mar; 22(11):3158-64. PubMed ID: 27003992
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide-induced angiopoietin 2, Notch1 and Dll4 downregulation under hypoxic condition in tissues with gastrointestinal vascular malformation and human umbilical vein endothelial cells.
Feng Q; Tan HH; Ge ZZ; Gao YJ; Chen HM; Xiao SD
J Dig Dis; 2014 Feb; 15(2):85-95. PubMed ID: 24219762
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide for refractory gastrointestinal bleeding from vascular malformations in patients with significant comorbidities.
Bayudan AM; Chen CH
World J Clin Cases; 2020 Aug; 8(15):3218-3229. PubMed ID: 32874976
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness and security of thalidomide for gastrointestinal bleeding and severe Crohn's disease in children].
Bauditz J
Z Gastroenterol; 2014 Oct; 52(10):1198-201. PubMed ID: 25313632
[No Abstract] [Full Text] [Related]
9. Thalidomide treatment in cirrhotic patients with severe anemia secondary to vascular malformations.
Garrido Serrano A; León R; Sayago M; Márquez JL
Dig Dis Sci; 2012 Apr; 57(4):1112-3. PubMed ID: 22089255
[No Abstract] [Full Text] [Related]
10. Evidence that thalidomide is effective in recurrent bleeding from watermelon stomach associated with liver cirrhosis.
Moser S; Tischer A; Karpi A; Schleicher M; Stavjanik S; Gschwantler M
Endoscopy; 2014; 46 Suppl 1 UCTN():E384. PubMed ID: 25254589
[No Abstract] [Full Text] [Related]
11. A pilot study of thalidomide in recurrent GI bleeding due to angiodysplasias.
Dabak V; Kuriakose P; Kamboj G; Shurafa M
Dig Dis Sci; 2008 Jun; 53(6):1632-5. PubMed ID: 17990111
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis and vascular malformations: antiangiogenic drugs for treatment of gastrointestinal bleeding.
Bauditz J; Lochs H
World J Gastroenterol; 2007 Dec; 13(45):5979-84. PubMed ID: 18023086
[TBL] [Abstract][Full Text] [Related]
13. [Thalidomide for recurrent gastrointestinal bleeding caused by angiodysplasia: report of one case].
Vega J; Goecke H; Rodríguez Mde L; Vergara MT
Rev Med Chil; 2011 Jul; 139(7):909-13. PubMed ID: 22051829
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide for treatment of severe intestinal bleeding.
Bauditz J; Schachschal G; Wedel S; Lochs H
Gut; 2004 Apr; 53(4):609-12. PubMed ID: 15016759
[TBL] [Abstract][Full Text] [Related]
15. [Thalidomide therapy for gastrointestinal angiodysplasia].
Bélard E; Foss CH; Christensen LA; Schmidt P; Nøjgaard C
Ugeskr Laeger; 2009 Nov; 171(47):3454-5. PubMed ID: 19925735
[TBL] [Abstract][Full Text] [Related]
16. [Thalidomide for the treatment of recurrent gastrointestinal blood loss due to intestinal angiodysplasias].
de Koning DB; Drenth JP; Friederich P; Nagengast FM
Ned Tijdschr Geneeskd; 2006 Sep; 150(36):1994-7. PubMed ID: 17002190
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide in refractory bleeding due to gastrointestinal angiodysplasias.
Garrido A; Sayago M; López J; León R; Bellido F; Márquez JL
Rev Esp Enferm Dig; 2012 Feb; 104(2):69-71. PubMed ID: 22372800
[TBL] [Abstract][Full Text] [Related]
18. [Angiogenesis inhibitors for treatment of angiodysplasia-related gastrointestinal bleeding].
Bauditz J
Dtsch Med Wochenschr; 2009 Sep; 134(38):1893-6. PubMed ID: 19746332
[No Abstract] [Full Text] [Related]
19. Successful treatment with thalidomide for a patient with recurrent gastrointestinal bleeding due to angiodysplasia diagnosed by capsule endoscopy.
Tan HH; Ge ZZ; Chen HM; Gao YJ
J Dig Dis; 2013 Mar; 14(3):153-5. PubMed ID: 23134426
[No Abstract] [Full Text] [Related]
20. Successful treatment with thalidomide of a patient with congenital factor V deficiency and factor V inhibitor with recurrent gastrointestinal bleeding from small bowel arteriovenous malformations.
Perez Botero J; Burns D; Thompson CA; Pruthi RK
Haemophilia; 2013 Jan; 19(1):e59-61. PubMed ID: 23171429
[No Abstract] [Full Text] [Related]
[Next] [New Search]
